Best Niche Antibody-based Biologics


Peter Rosenblum

Peter is the co-chair of Foley Hoag's Mergers and Acquisitions Group and Chair of its Private Equity Transactions Group. Peter is actively involved in the firm’s corporate and corporate finance practices and principal outside counsel to numerous public and private companies in technology, life sciences and other industries. Peter was Foley Hoag’s Co-Managing Partner from 2000 to 2005 and Chairman of its Business Department from 2008 to 2011.